Finance

Beta
Ask
Lists
TELA:NASDAQ
TELA Bio Inc
USD 0,80
-6,98%
(-0,060) 1D
USD 0,83
+3,75% (+0,030)
After hours
Closed: 15 Jun., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TELA...
Open
USD 0,90
High
USD 0,90
Low
USD 0,77
Mkt. cap
35,81 m
Avg. vol.
185,93 k
Volume
0,00
52-wk high
USD 2,20
52-wk low
USD 0,50
EPS
-USD 0,80
Beta
1,33
Shares outstanding
44,77 m
No. of employees
218
Open
USD 0,90
High
USD 0,90
Low
USD 0,77
Mkt. cap
35,81 m
Avg. vol.
185,93 k
Volume
0,00
52-wk high
USD 2,20
52-wk low
USD 0,50
EPS
-USD 0,80
Beta
1,33
Shares outstanding
44,77 m
No. of employees
218
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to TELA in the past 3 months
Strong Buy
Buy
3
Hold
1
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TELA in the last 3 months.
Highest
Current USD 0,80
USD 3,00 (+275,00%)
Average
USD 2,00 (+150,00%)
Lowest
USD 1,00 (+25,00%)
News stories
From sources across the web
About TELA Bio Inc
CEO-
Employees218
Founded2012
HeadquartersMalvern, Pennsilvanië, Verenigde State van Amerika
SectorMedical device
Websitetelabio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
20,20 m
20,69 m
20,87 m
19,06 m
Cost of goods sold
6,00 m
6,62 m
7,02 m
6,44 m
Cost of revenue
6,00 m
6,62 m
7,02 m
6,44 m
Research and development expenses
2,20 m
2,35 m
2,13 m
2,34 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,98 m
19,18 m
18,27 m
20,70 m
Operating expense
23,28 m
21,62 m
20,50 m
23,14 m
Total operating expenses
29,28 m
28,24 m
27,52 m
29,58 m
Operating income
-9,08 m
-7,55 m
-6,65 m
-10,53 m
Other non operating income
379,00 k
152,00 k
277,00 k
366,00 k
EBT including unusual items
-9,89 m
-8,60 m
-8,90 m
-12,21 m
EBT excluding unusual items
-9,89 m
-8,60 m
-8,01 m
-12,21 m
Income tax expense
33,00 k
-
145,00 k
60,00 k
Effective tax rate
-0,33%
-
-1,63%
-0,49%
Other operating expenses
-
-
-
-
Net income
-9,92 m
-8,60 m
-9,04 m
-12,27 m
Net profit margin
-49,13%
-41,58%
-43,32%
-64,39%
Earnings per share
-0,22
-0,19
-0,17
-0,21
Interest and investment income
-
-
-
-
Interest expense
-1,19 m
-1,20 m
-1,64 m
-2,05 m
Net interest expenses
-1,19 m
-1,20 m
-1,64 m
-2,05 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,81 m
-7,31 m
-6,42 m
-10,27 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer